decreased subcutaneous adipose tissue amount_Fbn1<tm2.1Hcd>/Fbn1<+>

http://metadb.riken.jp/0008844I129S1Sv129X1SvJC57BL6JFVBNFbn1tm21HcdFbn1Fbn1tm21HcdFbn1

decreased subcutaneous adipose tissue amount_Fbn1<tm2.1Hcd>/Fbn1<+>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• fibrillin 1
  http://metadb.riken.jp/db/mgi_rdf/MGI:95489

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Fbn1<tm2.1Hcd>/Fbn1<+>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Fbn1<tm2.1Hcd>|Fbn1<+>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased subcutaneous adipose tissue amount
  http://purl.obolibrary.org/obo/MP_0008844

文献

http://purl.org/net/cito/citesAsAuthority

• Elizabeth E. Gerber, et.al., Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma., Nature, 2013, 503
  http://rdf.ncbi.nlm.nih.gov/pubmed/24107997